Tag: TCT 2021
TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal...
Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing endovascular ultrasound renal denervation to a sham procedure for treatment-resistant hypertension, demonstrate the additional effects...
Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study
Medtronic today announced findings from a new study of patient preferences for the treatment of hypertension. The findings are set to be presented during...
Procyrion’s Aortix percutaneous mechanical circulatory support device features at TCT 2021
Procyrion has announced the presentation of studies at the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021, 4–6 November, Orlando USA and virtual) relating to...